Buchumschlag

Generic imatinib in the treatment of chronic myeloid leukemia: two years’ experience in latvia

Background: Imatinib is tyrosine kinase inhibitor (TKI) and as a targeted anti-cancer agent has significantly changed chronic myeloid leukemia (CML) prognosis and patient survival. Currently TKI is the main therapy in CML Philadelphia chromosome-positive (Ph-positive) cases. When generics of imatini...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Experimental Oncology
Datum:	2017
Hauptverfasser:	Lejniece, S., Udre, I., Rivkina, A.
Format:	Artikel
Sprache:	Englisch
Veröffentlicht:	Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України 2017
Schlagworte:	Original contributions
Online Zugang:	https://nasplib.isofts.kiev.ua/handle/123456789/137976
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!
Назва журналу:	Digital Library of Periodicals of National Academy of Sciences of Ukraine
Zitieren:	Generic imatinib in the treatment of chronic myeloid leukemia: two years’ experience in latvia / S. Lejniece, I. Udre, A. Rivkina // Experimental Oncology. — 2017 — Т. 39, № 2. — С. 151–154. — Бібліогр.: 14 назв. — англ.

Institution

Digital Library of Periodicals of National Academy of Sciences of Ukraine

Ähnliche Einträge

Functional activity of CD34-positive cells in chronic myeloid leukemia patients with different response to imatinib therapy
von: Sviezhentseva, I.O., et al.
Veröffentlicht: (2015)

Peripheral blood lymphocyte phenotype of ZAP-70⁺ and ZAP-70⁻ patients with B-cell chronic lymphocytic leukaemia
von: Rivkina, A., et al.
Veröffentlicht: (2015)

Baseline serum levels of multiple cytokines and adhesion molecules in patients with acute myeloid leukemia: results of a pivotal trial
von: Kupsa, T., et al.
Veröffentlicht: (2014)

TP53 codon 72 single nucleotide polymorphism in chronic lymphocytic leukemia
von: Bilous, N.I., et al.
Veröffentlicht: (2014)

Analysis of the 3′UTR region of the NOTCH1 gene in chronic lymphocytic leukemia patients
von: Abramenko, I.V., et al.
Veröffentlicht: (2018)

Combined antiproliferative activity of imatinib mesylate (STI-571) with radiation or cisplatin in vitro
von: Yerushalmi, R., et al.
Veröffentlicht: (2007)

Characteristics of clones with additional chromosomal abnormalities in patients with chronic myeloid leukemia and their impact on the imatinib therapy efficacy
von: I. V. Dmytrenko, et al.
Veröffentlicht: (2019)

IGHV3-21 gene expression in patients with b-cell chronic lymphocytic leukemia in Ukraine
von: Abramenko, I., et al.
Veröffentlicht: (2007)

CD150 and CD180 are involved in regulation of transcription factors expression in chronic lymphocytic leukemia cells
von: Gordiienko, I.M., et al.
Veröffentlicht: (2017)

Functional activity of CD34-positive cells in chronic myeloid leukemia patients with different response to imatinib therapy
von: I. O. Sviezhentseva, et al.
Veröffentlicht: (2015)

The distribution of TP53 gene polymorphisms in chronic lymphocytic leukemia patients, sufferers of chornobyl nuclear power plant accident
von: Bilous, N.I., et al.
Veröffentlicht: (2016)

Identifying the stage of new CLL patients using TK, ZAP-70, CD38 levels
von: Rivkina, A., et al.
Veröffentlicht: (2011)

The value of initial clinical and laboratory parameters in the prognosis of the nilotinib therapy response in patients with chronic phase of chronic myeloid leukemia with ineffective imatinib therapy
von: I. V. Dmytrenko, et al.
Veröffentlicht: (2019)

Comparison of chromosomal rearrangements in bone marrow cells and blast transformed B-cells in relapse of B-cell chronic lymphocytic leukemia/ small lymphocytic lymphoma
von: Andreieva, S.V., et al.
Veröffentlicht: (2017)

Detection of notch1 c.7544_7545deICT mutation in chronic lymphocytic leukemia using conventional and real-time polymerase chain reaction
von: Bilous, N.I., et al.
Veröffentlicht: (2016)

Glycopeptide vaccine on DNA-histone carrier and its impact on ζ-potential of effector cells during experimental treatment of lymphoblastic leukemia
von: Janisch, Yu.V., et al.
Veröffentlicht: (2013)

The immunophenotype of adult t acute lymphoblastic leukemia in Morocco
von: Lahjouji, A., et al.
Veröffentlicht: (2015)

Pharmacological effect of aminoferrocene in mice with L1210 leukemia
von: Chekhun, V.F., et al.
Veröffentlicht: (2015)

Chronic myeloid leukemia in patient with the klinefelter syndrome
von: Andreieva, S.V., et al.
Veröffentlicht: (2016)

Impact of endostatin gene therapy on myeloid-derived suppressor cells from a metastatic renal cell carcinoma
von: Chaves, K.C.B., et al.
Veröffentlicht: (2018)

The TGF-beta — SMAD pathway is inactivated in cronic lymphocytic leukemia cells
von: Matveeva, A., et al.
Veröffentlicht: (2017)

Initial experience with using frameless image-guided radiosurgery for the treatment of brain metastases
von: Liepa, Z., et al.
Veröffentlicht: (2012)

Photodynamic responsiveness of human leukemia Jurkat/A4 cells with multidrug resistant phenotype
von: Philchenkov, A.A., et al.
Veröffentlicht: (2014)

Quantitative real time PCR analysis of apoptosis-related gene expression in leukemias in ukrainian patients
von: Savli, H., et al.
Veröffentlicht: (2011)

Differentiating effect of thalidomide and GM-CSF combination on HL-60 acute promyelocytic leukemia cells
von: Ural, A.U., et al.
Veröffentlicht: (2006)

In vivo and in vitro antitumor effects of nutrient mixture in murine leukemia cell line P-388
von: Roomi, M.W., et al.
Veröffentlicht: (2011)

Biochemical markers and assessment of cardiotoxicity during preparative regimen and hematopoietic cell transplantation in acute leukemia
von: Horacek, J.M., et al.
Veröffentlicht: (2007)

The use of cardiac biomarkers in detection of cardiotoxicity associated with conventional and high-dose chemotherapy for acute leukemia
von: Horacek, J.M., et al.
Veröffentlicht: (2010)

Nutrient mixture inhibits in vitro and in vivo growth of human acute promyelocytic leukemia HL-60 cells
von: Roomi, M.W., et al.
Veröffentlicht: (2011)

Differentiated thyroid carcinomas associated with chronic thyroiditis: biological and clinical properties
von: Myshunina, T.M., et al.
Veröffentlicht: (2018)

L-arginine is an effective medication for prevention of endothelial dysfunction, a predictor of anthracycline cardiotoxicity in patients with acute leukemia
von: Skrypnyk, I., et al.
Veröffentlicht: (2017)

Aberrant promoter hypermethylation of selected apoptotic genes in childhood acute lymphoblastic leukemia among north indian population
von: Nikbakht, M., et al.
Veröffentlicht: (2017)

Drug resistance associated properties of blasts subpopulations with different CD34 expression in childhood acute lymphoblastic leukemia (ALL)
von: Shman, T.V., et al.
Veröffentlicht: (2011)

Growth inhibition and apoptosis induced by 2 phenoxymethyl-3H-quinazolin-4-one in HL-60 leukemia cells
von: Cipak, L., et al.
Veröffentlicht: (2007)

Prognostic value of the bone turnover markers in multiple myeloma
von: Auzina, D., et al.
Veröffentlicht: (2017)

Cannabinoid receptors expression in bone marrow trephine biopsy of chronic lymphocytic leukaemia patients treated with purine analogues
von: Piszcz, J.A., et al.
Veröffentlicht: (2007)

Features of the molecular expression of alkaline phosphatase gene in chronic myeloid leukemia
von: L. P. Shvachko, et al.
Veröffentlicht: (2017)

Thrombotic complications during cancer treatment in children
von: Lipay, N.V., et al.
Veröffentlicht: (2007)

Treatment of large osteosarcoma in children: new approach
von: Kobys, V.L., et al.
Veröffentlicht: (2013)

Impact of systemic hypoxemia on cancer aggressiveness and circulating vascular endothelial growth factors A and C in gastroesophaeal cancer patients with chronic respiratory insufficiency
von: Krzystek-Korpacka, M., et al.
Veröffentlicht: (2007)